Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Retacrit

(REH-tuh-krit)
A drug used to treat anemia caused by chronic kidney disease, some types of chemotherapy, and an antiviral drug for HIV infection called zidovudine. It is also used to lower the number of donor blood transfusions needed during and after certain types of surgery. Retacrit is a form of erythropoietin (a substance naturally made by the kidneys) that is made in the laboratory. It helps the bone marrow make more red blood cells. Retacrit is a type of antianemic and a type of erythropoiesis-stimulating agent. Also called epoetin alfa, Epogen, and Procrit.
Search NCI's Dictionary of Cancer Terms